Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE)
Clinical trial NCT01779479 · COMPLETED
Trial details
- NCT number
- NCT01779479
- Sponsor
- GBG Forschungs GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2015-08-01
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.